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Abstract
Pharmacist-led initiatives have recently emerged as viable
strategies for reducing healthcare disparities in diabetes which, as
the 7th leading cause of death in America, has increasingly become
a concern for minority groups. Following a literature review that
focuses on the main factors influencing disparities and pharmacyled interventions in diabetes, two strategies are suggested to
increase the role that pharmacists can play in reducing diabetes
health care disparity: 1) develop culturally competent
interventions to increase the ability of pharmacists to educate and
counsel patients, and 2) increase pharmacists’ prescribing power
within the health care provider team. Several studies link cost of
treatment, socio-economic status, and racial differences with longterm adherence to diabetes medication and demonstrate that
increased culturally competent pharmacist involvement in patient
care can decrease costs and increase patient adherence, thereby
reducing disparity. Pharmacists are critical to the formulation of
interventions that seek to eliminate health care disparities.
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Introduction
Healthcare reform is one of the most
pressing and controversial challenges that the
American people currently face. Despite the
variety of viewpoints surrounding this issue, there
is overwhelming agreement that health care
disparities are a major source of inefficiency in the
health care system. The ultimate goal of health
care reform is the elimination of health care
disparities across all disease states. In order to
accomplish this goal, health care providers must
focus on interventions that yield the greatest
positive change in the shortest time, which implies
targeting diseases which are most prevalent within
the population.
Health care disparities are defined by
observable inequalities in access to, use of, and
quality of health care services within a population.
Inequities in cost, quality and access to care are
the preferred targets for provider led initiatives to
eliminate disparity because of the influence that
health care professionals have over the services
that they provide. Although the incidence
(percentage of new cases), prevalence (percentage
of total cases) and mortality (percentage of deaths)
of a disease within a specific population over a
period of time may appear disparate, disparities in
quality, cost or access to health care may not
always be the root of the problem. Socioeconomic,
environmental and genetic factors, among others,
often account for disparities in specific diseases
within a population, increasing the complexity
involved in addressing this issue.
Providers seeking to construct effective
interventions must consider both the prevalence
and the significance of health disparities
associated with specific disease targets. Because
of the limited resources allocated for health
disparity elimination, focusing on such diseases as
diabetes, asthma, or hypertension, is necessary in
order to achieve swift, significant success.

Diabetes deserves special consideration in
Louisiana, where both the prevalence of the
disease is high and health care disparities are
significant.
We are proposing two interventions aimed
at reducing health care disparities associated with
diabetes: 1) develop culturally competent
interventions to increase the ability of pharmacists
to educate and counsel patients, and 2) increase
pharmacists’ prescribing power within the health
care provider team. First, we begin by
demonstrating that diabetes is an appropriate
target for interventions that aim to reduce health
disparity. Next, we identify factors that influence
health care disparities associated with adherence
to diabetes treatment. Third, we present the two
proposed interventions to decrease disparities in
diabetes and, finally, we discuss the benefits and
barriers of increasing pharmacist prescribing
power.

Diabetes: A Target in Health Disparities
Diabetes is a broad classification used to
categorize a group of lifelong chronic diseases.
The most common type, Diabetes mellitus, is a
disease in which the blood contains high levels of
glucose (high blood sugar or hyperglycemia),
either because the body does not produce enough
insulin (type 1) or because cells do not respond to
the insulin that is produced (type 2). The clinical
implications of this pathology are far reaching.
The Centers for Disease Control and Prevention
(CDC) named diabetes as the foremost cause of
renal failure, appendage amputation not associated
with trauma, and new cases of adult onset
blindness (2011). Additionally, diabetes is a major
contributor to the incidence of heart disease and
stroke, and ranked 7th in the top 10 causes of death
in America (CDC, 2011).
Because type 1 diabetes is an autoimmune
disease with genetic origins, health disparities
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associated with this disease are caused by factors
other than cost, quality or access to health care
services. Type 2 diabetes, in contrast, is an
acquired disease with risk factors including
obesity, inactive lifestyle, and unhealthy
nutritional habits. The impact of type 2 diabetes is
both preventable and reversible if diagnosed and
treated promptly. According to the CDC (2011),
diabetes mellitus type 2 represents 90-95% of
diagnosed cases. These characteristics of diabetes
mellitus type 2 make this disease an ideal focal
point for interventions that seek to reduce health
care disparities. As a result, this paper is
exclusively focused on health care disparities
associated with diabetes mellitus type 2, formerly
called non-insulin-dependent diabetes mellitus
(NIDDM), and will be referred to here as
“diabetes.”
Many initiatives address the increasing
problems associated with diabetes disparity.
Healthy People 2020 (HP 2020), sponsored by the
U.S. Department of Health and Human Services,
has undertaken the task of prioritizing goals with
specific benchmarks for many diseases that are of
particular concern to the American population.
The stated intent of HP 2020 is to improve the
health of all Americans, and not only addresses
disparity directly, but also emphasizes the
importance of patient education, compliance with
diagnostic testing for diabetes and co-morbid
diseases, engaging in healthy eating habits and the
need for positive patient outcomes. The efficiency
of any initiative in reducing health care disparities
or disease prevalence can only be determined by
measuring the outcomes of that initiative against a
standard. The provision of these standards by HP
2020 has given health care providers the ability to
implement successful initiatives that can both
reduce the prevalence of diabetes and reduce
health care disparities associated with the disease.

Disparities in diabetes in Louisiana
According to the Louisiana Department of
Health Diabetes Report (McCoy et al., 2010),

7.8% of the total US population and 10.1% of the
Louisiana population had been diagnosed with
diabetes in 2007. Healthy People 2020 states that
nationally, African Americans are 1.7 times more
likely to be diagnosed with diabetes than nonHispanic whites (DHHS, 2010). In Louisiana,
diabetes prevalence was 13.6% for African
Americans and 8.8% for Caucasians (McCoy et
al., 2010).
In addition to racial or ethnic disparity in
diabetes prevalence, the Louisiana Diabetes
Report describes socio-economic inequities stating
that individuals earning less than $25,000
(accounting for 54.8% of the sample population in
2007) experienced 15.9% diabetes prevalence
(McCoy et al., 2010). This figure is significantly
higher than both the Louisiana and national
average. Interpretation of the fiscal data associated
with diabetes is particularly revealing because of
the three factors that influence healthcare disparity
(cost, quality and access), cost is the easiest to
measure. In Louisiana, the cost of diabetes-related
expenditures was $6,235 per patient for white
males compared to $8,198 for African-American
males (McCoy et al., 2010). These statistics paint
the picture of a disease that is highly prevalent
within the general population, has a greatly
increased prevalence amongst minority groups,
and imposes a heavier burden of treatment on
minority patients with regard to cost and access to
quality care. These attributes indicate that a
reduction in diabetes healthcare disparity will
result in a significant reduction in diabetes
prevalence within the general population.

Factors Influencing Adherence to
Diabetes Treatment
A literature review of factors associated
with diabetes health care disparity found that the
most relevant studies focused on the impact of two
main factors contributing to disparities in
adherence to treatment: 1) racial and ethnic
differences, and 2) socioeconomic status
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Impact of race and ethnicity in adherence
to treatment
Adherence to treatment is a major
challenge to eliminating disparity. A retrospective
cohort study (Trinacty et al,2009) looked at racial
disparity in adherence to long term diabetes drug
regimens within the Boston area. The study
accounted for accessibility and quality of care by
using only those patients enrolled in a Health
Maintenance Organization (HMO) that offered
prescription coverage. Analyzing 10 years of
prescription records along with data from clinical
and pharmacy claims, the study demonstrates both
long term and short term differences in adherence
between races. Specifically, the study analyzed
patient information with regard to prescriptions
written and prescriptions filled for oral diabetes
medication. The study ensured equal access to
medication by considering 1,906 patients that had
the same type of prescription coverage and
assessed long term adherence by calculating the
monthly average rate of adherence.
Interpretation of the data showed
differences in adherence between races to varying
degrees throughout the 24 month follow up, but
the African American group consistently
demonstrated higher rates of treatment cessation.
By the end of the follow up assessment over half
of the African American group had discontinued
therapy for 60 days or more whereas only 44% of
the Caucasian group had. This study shows that
racial differences in compliance to a long term
drug regimen for oral diabetes medication are
significant, with African American patients being
more likely to cease treatment than Caucasian
patients. This study confirms that given equal
access to diabetes drug treatment, there is a link
between race and adherence to long term drug
regimens.

Impact of low socio-economic status in
adherence to treatment
Two studies (LaVeist et al., 2009 and the
Chernew et al., 2008) analyzed statistically

significant relations between race/ethnicity
income, and adherence. Both studies concluded
that income plays an important role in explaining
racial/ethnic disparities in diabetes and that
reducing the cost of medication for low-income
patients can greatly contribute to reducing health
disparities.
LaViest et al. (2009) demonstrated the
effect income has on patient health outcomes by
comparing two surveys. The first, Exploring
Health Disparities in Integrated CommunitiesSouthwest Baltimore (EHDIC-SWB), was a 2003
cross sectional study with 1489 participants of
similar race and low economic status (LaVeist et
al, 2008). The second survey considered was the
2003 National Health Interview Survey (NHIS)
conducted by the US Census Bureau with 29,372
participants who exhibited significant racial
disparity with more African-American participants
earning less than $10,000 a year than Caucasian.
The results showed that the NHIS ratio of diabetes
prevalence for African Americans compared to
Caucasians was 1.57 while the EHDIC-SWB
survey ratio was only 1.03. By comparing the
NHIS survey with the EHDIC-SWB survey, the
authors demonstrated that socio-economic
inequality is linked with a racially disparate
diabetes distribution and that a reduction in socioeconomic inequality coincides with a reduction in
racial/ethnic disparity. This analysis confirms that
racial/ethnic disparity in diabetes is associated
with socio-economic disparity.
Chernew et al. (2008) assessed socioeconomic disparities in diabetes treatment using a
large employer-based insurance company database
(6 million workers) from 2002 to 2004. The
authors considered diabetes and congestive heart
failure and analyzed adherence to medication
regimens and mean income by zip code as stated
in the 2000 census. The study showed a 1.08 ratio
of adherence to diabetes medication from high
income to low income. The authors compared
income by assessing four distinct income brackets.
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The lowest income group earned less than $30,000
whereas the highest income group earned more
than $62,000. In the diabetes group, the highest
income bracket was 20% more compliant to drug
regimens than the lowest income bracket. The
authors concluded the study by proposing a co-pay
relief intervention in order to increase adherence
amongst those patients who have lower incomes.
This study confirms that cost is a major
contributor to socio-economic health care
disparity.

Interventions to Decrease Disparities
in Diabetes
A literature review of effective prevention
techniques found that the most relevant studies
focused on the impact of two main initiatives to
decrease disparities: 1) implementation of
culturally-competent
interventions
involving
pharmacists counseling, and 2) increase of
pharmacist’s prescribing power. Results of these
studies confirm the important impact that
empowering the pharmacist to provide expanded
culturally competent services within a primary
care team can have on increasing patient
adherence and decreasing cost of treatment, and,
as a result, on decreasing health disparities.

Impact of culturally-competent
interventions on reducing disparities
A systematic literature review of
interventions published between 1985 and 2006
(Peek, Cargill, and Huang, 2008), assessed the
effects of education and counseling on diabetes
disparity. This review compared 48 reports on 43
studies, two thirds of which were controlled. The
authors classified the interventions into three
categories: patient, provider, and system-wide
interventions. All of the patient interventions
involved patient education programs which
focused on diet, exercise and self-management
and were intended to increase adherence to
recommended lifestyle modifications or selfassessment regimens including blood glucose

testing. Provider-based interventions sought to
improve patient outcomes by offering physician
education and alert systems. The system-wide
interventions utilized healthcare providers other
than physicians, including registered nurses and
pharmacists who offered increased clinical and
medication management services, respectively, in
order to reduce diabetes disparity.
Further division of the interventions
differentiated those that were culturally tailored
from those that were generally applied to all
patients.
Culturally
tailored
interventions
attempted to consider the culture and individual
characteristics of patients in order to most
effectively impact patient adherence and improve
patient outcomes.
Although the patient
interventions considered to be culturally sensitive
did not consistently result in a reduction in target
laboratory values, one-on-one consultation and
peer counseling did improve patient health more
than computer or automated initiatives did. The
provider-based interventions offered no initiatives
considered to be culturally ‘tailored’; however, the
authors did infer that an increase in health care
provider training for treatment of diabetes would
lead to increased access to specialized diabetes
care for minorities, which has the potential to
reduce health care disparity in diabetes. Within the
health system-wide intervention group two studies
assessed pharmacist-led medication management
and education, which resulted in lower HbA1c
values, increased patient understanding of the
disease and an increase in overall satisfaction with
the health services provided. The study concluded
that patient, provider, and system interventions
can all be effectively employed to reduce health
care disparity in diabetes. The most effective
interventions were personalized, accounted for
cultural differences and utilized the collaborative
healthcare team model to increase positive patient
outcomes and satisfaction.
Another study published by Morello
(2011) analyzed the results of a cross-sectional
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survey regarding self-adherence and methods
perceived to be effective at increasing adherence,
distributed amongst patients and caregivers
attending the 2005 Taking Control of Your
Diabetes conference in San Diego. Response rate
was 40.5% with 524 total submissions. The
authors found that three of the factors that most
positively
influenced
medication
therapy
compliance involved patient understanding of the
purpose, goals and complications of drug
treatment regimens and recommended pharmacistled initiatives to educate and counsel patients
regarding the benefits of drug therapy and
techniques to increase adherence. This study
shows that culturally competent education and
counseling can be effective methods for
eliminating this particular factor of health care
disparity.

Impact of pharmacist prescribing power on
reducing treatment costs
Dole (2007) explored the benefits of
adhering to the healthcare team model by
examining the implications of pharmacist
prescribing at a pain clinic in New Mexico.
According to provisions enacted in 1993 under the
Pharmacist Prescriptive Authority Act, clinical
pharmacists are allowed to prescribe under the
supervision and in collaboration with a physician
in accordance with specified pre-determined
protocols. Data collected included patient
assessment of pain, cost savings, revenue
generation, and adherence to medication safety
standards. The results showed a significant
reduction in patient pain and cost with a savings of
nearly a half a million dollars to the insurance
companies billed within one year. The revenue
recorded by the clinic exceeded the salary of the
pharmacist. Additionally, pharmacist involvement
facilitated an increase to the efficacy of the triage
process by eliminating the necessity of physicians
seeing patients who required only medication
management. This allowed the clinic to maintain
adequate safety standards. Although this study
does not address diabetes specifically, the

conclusions may be applied to those disease states,
like diabetes, that are both chronic and require
ongoing medication therapy management.
Two interventions reported separately by
Rodgers and colleagues (1999) and Walker &
Mathers (2002) described the effects of both
increasing pharmacist prescribing power and of
the primary care group approach to health care on
prescribing costs. Although these interventions did
not address disparity directly, the lowering of
prescribing costs assessed by these interventions
can be applied to strategies that reduce diabetes
health care disparity by reducing financial barriers
to healthcare. The first intervention in Doncaster,
England (Rogers et al., 1999) assessed the effects
of a pharmacist intervention on prescribing costs
and involved eight medical practices where
pharmacists assisted by modifying drug regimens
and offering patient counseling and education. The
study assessed prescribing data, accounted for
variance within the populations of the practices
and noted significant differences between the
control and test groups. The authors concluded
that the intervention diminished enough of the
prescribing costs to pay the pharmacists for their
services.
The second intervention, a comparison
study, in South Derbyshire, England (Walker &
Mathers, 2002), included nine practices that had
enacted a primary care group initiative in which a
pharmaceutical advisor was employed to consult,
provide feedback, and make recommendations.
The authors assessed prescribing data regarding
cost and compared the results to a control group.
Test group expenditures dropped below the
control group’s expenditures within one month of
employing the initiative. This study demonstrates
how collaborative prescribing by professionally
diverse members of a health care team can lower
prescribing costs. Together, these studies show
that increasing the role of the pharmacist within
the health care team can effectively reduce
prescribing costs. This will have the greatest effect
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on disparity for those diseases like diabetes, which
are most prevalent and which require the most
drug intensive treatment.

Barriers to and Benefits of Pharmacists
Prescribing Power
California,
Florida,
New
Mexico,
Washington and health services provided by the
federal government including the Veterans Health
Administration have pioneered the way for
increasing the role of the pharmacists within the
health care team. Florida was one of the first states
to enact any kind of provision for pharmacist
prescribing giving pharmacists the “outright
statutory authority” to “independently” prescribe a
limited list of drugs.
Doering (2007) reviewed the history of the
Florida statue along with some of the pitfalls and
benefits of the law. The author sees a number of
problems with increasing pharmacist prescriptive
authority which echoes many of the objections
that opponents to pharmacist prescribing have
raised. The more important objection is patient
safety and the potential for misdiagnosis.
Pharmacists lack extensive diagnostic training and
should not attempt to expand their scope of
practice beyond their education. Rather, the focus
of the pharmacist as a patient care provider should
be on the management of patient medication
regimens and the provision of patient education.
Doering , in spite of his misgivings, conceded that
pharmacist prescribing can lead to a decrease in
cost and an increase in patient satisfaction. As
long as the lessons learned from the Florida model
can be incorporated into interventions that
increase the role of the pharmacist within the
health care team, cost can be reduced without
sacrificing patient safety. These initiatives will
provide the most useful information about the cost
benefits, safety and efficacy of pharmacist
prescribing which may assist the rest of the nation
in adopting similar policies.

In order to implement a policy that
increases the pharmacist’s power to treat diabetes
and educate patients, three distinct phases would
have to occur. The first is legislative. In his
retrospective analysis of Florida’s prescribing
laws, Doering (2007) describes the process by
which prescriptive authority policy is constructed
and asserts that this process occurs exclusively at
the state level. Policy regarding pharmacist
prescriptive authority throughout American
history has swung with public sentiment on a
pendulum between two opposing social values:
safety and accessibility. Over the last 40 years, as
public sentiment has shifted away from safety and
regulation in favor of increased accessibility, more
and more states have drafted legislation that
expands the scope of pharmacist prescriptive
authority. The first states to enact these policies,
however, did not have access to the extensive
body of data that is available for policy makers
today. The assessment of the initiatives enacted by
these progressive states is critical to the discussion
of expanding pharmacists’ prescriptive authority
in states that have not already enacted similar
policies. Support for these initiatives will only
come from lawmakers of states more apprehensive
to increasing the scope of pharmacy practice after
both the safety and efficacy of pharmacist
prescribing is confirmed. Although this data
continues to accumulate as more states implement
and assess the outcomes of these initiatives, many
more studies are needed in order to demonstrate a
positive impact on diabetes and diabetes-related
illnesses,
particularly
within
minority
communities.
Once the political road has been paved,
pharmacists would have to prepare themselves for
an increase in responsibilities. A certification
process would need to be enacted. ShaneMcWhorter (2005) wrote a recommendation for
the scope of pharmaceutical practice which
specifically describes the role pharmacists play as
diabetes
educators.
This
recommendation
emphasizes the need for pharmacists to receive
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certified, ongoing, disease-specific education in
order to educate their patients. Not only should
pharmacists be subjected to intensive education
regarding all aspects of the disease, but they
should also be educated on how to relay that
information effectively to their patients. Both of
these educational requirements would have to be
above and beyond the standard pharmacy
education and would most certainly require
ongoing re-certification.
The third phase of these initiatives would
involve corporate restructuring. As local
pharmacies begin to offer expanded services to
their patients, the companies behind these
pharmacies would have to devise new staffing and
billing solutions. An analysis of the ways in which
pharmacists have contributed to diabetes care in
America by Armour et al. (2009) concluded that
despite the significant reduction in costs
associated with increasing the role of the
pharmacist in patient care and education, the
process
by
which
pharmacists
receive
compensation for these services is often
inefficient. Additionally, the goal of these
initiatives is not to eliminate physician
participation, but to utilize the untapped resources
that pharmacists are able to offer. The health care
team model functions most efficiently when power
is disseminated amongst all members. In order to
maintain the structure of the health care team
model, pharmacy corporations would have to
construct an appropriate network of physicians
and other health care providers into which the
expanded role of the pharmacist must be
integrated. The pharmacist must be provided with
access to a health care team for consultation in
order to maximize positive patient outcomes.
Increasing the power of pharmacists to
treat diabetes and educate patients will have a
bilateral effect on the disease by reducing both
disparity and prevalence. These initiatives will
have the greatest positive effects in areas like
Louisiana that have high diabetes prevalence and

disparity. Healthy People 2020 suggested that the
increasing prevalence of diabetes may cause
dwindling attention and resources available to
treat the disease. The lack of resources is most
hard felt within minority communities. In order to
stem the tide of diabetes affliction, patients need
access to affordable health care and education.
One way to increase the number of
diabetes health care providers while decreasing
costs is to empower pharmacists to treat patients
within specific disease states by prescribing and
managing drug treatment regimens. Increasing the
role of pharmacists within the framework of the
health care team has the potential to alleviate
many of the burdens of inefficiency placed upon
the health care system by disparity and lack of
access. Those patients who are least likely to see a
physician regularly would benefit the most.
Development and implementation of a drug
treatment strategy could occur at any number of
local pharmacies which would drastically increase
the number of facilities providing these services.
Additionally, those pharmacists who are
empowered to treat diabetes will also be in a
unique position to offer education and counseling
that is culturally specific to the community that
they serve. Increasing education has been linked
with increased adherence, which for diseases with
long term drug regimens like diabetes, often
diverges along racial and socio-economic lines.

Conclusion
Because of the high rate of diabetes
prevalence, eliminating diabetes disparity is a
critical goal of health care reform in Louisiana.
Both cost and adherence to treatment are major
obstacles to achieving equitable access to health
care for minority groups. Studies described in this
literature review show that decreasing the cost of
diabetes treatment while offering individual
patients comprehensive, culturally targeted
education will result in a decrease in health care

XULAneXUS: Xavier University of Louisiana’s Undergraduate Research Journal
https://digitalcommons.xula.edu/xulanexus/vol9/iss2/2

8

Gauthier: Pharmacists Form the Frontline Against Disparities in Diabetes

Special Relationships
Pharmacists
Frontline

15

!

disparities with regard to both financial
accessibility and adherence to treatment.
Provider-led interventions are crucial to
the movement to eliminate diabetes health care
disparity and can be of great benefit to
communities that are both racial/ethnic minorities
and those of lower income; these are the
communities most in need of relief in Louisiana.
Pharmacists have begun to play a front line role in
disparity elimination and have the potential to
significantly reduce many of the factors that
contribute to diabetes disparity. Pharmacist-led
interventions
conducted
by
empowered
pharmacists capable of taking on more
responsibilities within the primary care team and
offering effective personalized patient counseling
and education, can reduce health care disparity in
diabetes treatment by decreasing prescribing costs
and making specialized diabetes care more
accessible to lower income and minority patients.

Limitations and Recommendations
The greatest challenge to an intervention
that seeks to increase pharmacist influence is the
construction of an infrastructure that can
accommodate the expansion of the pharmacist’s
role while maintaining the safety and efficacy of
treatment. Accountability of pharmacists to a
health care team would have to be established
before lawmakers and accrediting organizations
could stand behind any initiative that expands
prescribing power. Concentration of prescribing
and dispensing powers is commonly seen as a
safety concern. A network of health care providers
must be available for pharmacists to consult with
regarding course of treatment for patients in order
to maintain accountability. Recent advances in
communication technology are making the
possibility of such a network an increasing reality.
Cost is a challenge to the initiative to
provide pharmacists with cultural competence and
effective counseling training. In addition to the
training costs, the time required to perform

consultations represents labor costs. Pharmacies
would have to staff according to the new demands
associated with increased consultation and
develop standards by which they can be
reciprocated for their services.
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